Figure 4
From: Integrative pan-cancer analysis of MEK1 aberrations and the potential clinical implications
MEK1 mutation distribution by targeted therapy implication. (A) MEK1 mutation distribution by treatment level evidence as annotated in OncoKB. (B) MEK1 mutation distribution by targeted treatment in the top 12 types of cancer.
